Witold Kycler1, Bronisława Szarzyńska2, Cezary Loziński1, Konstanty Korski3, Katarzyna Lamperska2. 1. Department of Oncological Surgery II, Greater Poland Cancer Centre, 15 Garbary St., 61-866 Poznan, Poland. 2. Cancer Genetics Laboratory, Great Poland Cancer Centre, Poznan, Poland. 3. Department of Pathology, Greater Poland Cancer Centre, Poznan, Poland.
Abstract
BACKGROUND/AIM: The aim of our study was to check how MGMT methylation status together with known factors influenced the risk of colon cancer development. MATERIALS AND METHODS: We examined patients with colon polyps. Information concerning gender, age, lifestyle, diet, anthropometry and medical information, including cancer and family history of cancer, was analyzed. Polymorphism variety of MGMT gene was investigated in another study. Genetic analysis for MGMT methylation assessment was performed for polyp tissue samples from 143 patients. RESULTS: Positive methylation MGMT status was found in 55 patients. There was no correlation between gender and MGMT methylation status (p = 0.43). We did not find correlation between patients younger and older than 60 (p = 0.87). There was no correlation between smoking and MGMT methylation status (p = 0.36). We did not find correlation between BMI and MGMT methylation status (p = 0.86). We did not find correlation between MGMT methylation status and colon cancer in familial history (p = 0.45). CONCLUSION: Our study showed no correlations between methylation status of MGMT polymorphisms and clinical features like age, gender, polyp localization, smoking status, or obesity. It has been shown previously that MGMT methylation status may show nonspecific methylation in colon polyps. Gene methylation status in adenoma tissues has also been associated by other authors with the adenoma's size, histology, and degree of atypia. In our study, we evaluated the gene methylation status in colon polyps and found no association with adenoma characteristics. The present study showed no correlation for MGMT methylation in polyps in different regions of colon.
BACKGROUND/AIM: The aim of our study was to check how MGMT methylation status together with known factors influenced the risk of colon cancer development. MATERIALS AND METHODS: We examined patients with colon polyps. Information concerning gender, age, lifestyle, diet, anthropometry and medical information, including cancer and family history of cancer, was analyzed. Polymorphism variety of MGMT gene was investigated in another study. Genetic analysis for MGMT methylation assessment was performed for polyp tissue samples from 143 patients. RESULTS: Positive methylation MGMT status was found in 55 patients. There was no correlation between gender and MGMT methylation status (p = 0.43). We did not find correlation between patients younger and older than 60 (p = 0.87). There was no correlation between smoking and MGMT methylation status (p = 0.36). We did not find correlation between BMI and MGMT methylation status (p = 0.86). We did not find correlation between MGMT methylation status and colon cancer in familial history (p = 0.45). CONCLUSION: Our study showed no correlations between methylation status of MGMT polymorphisms and clinical features like age, gender, polyp localization, smoking status, or obesity. It has been shown previously that MGMT methylation status may show nonspecific methylation in colon polyps. Gene methylation status in adenoma tissues has also been associated by other authors with the adenoma's size, histology, and degree of atypia. In our study, we evaluated the gene methylation status in colon polyps and found no association with adenoma characteristics. The present study showed no correlation for MGMT methylation in polyps in different regions of colon.
Authors: M Esteller; R A Risques; M Toyota; G Capella; V Moreno; M A Peinado; S B Baylin; J G Herman Journal: Cancer Res Date: 2001-06-15 Impact factor: 12.701
Authors: D L Worthley; V L J Whitehall; R L Buttenshaw; N Irahara; S A Greco; I Ramsnes; K-A Mallitt; R K Le Leu; J Winter; Y Hu; S Ogino; G P Young; B A Leggett Journal: Oncogene Date: 2009-12-07 Impact factor: 9.867
Authors: Marsha L Frazier; Lixuan Xi; Jihong Zong; Nancy Viscofsky; Asif Rashid; Elsie F Wu; Patrick M Lynch; Christopher I Amos; Jean-Pierre J Issa Journal: Cancer Res Date: 2003-08-15 Impact factor: 12.701
Authors: Victoria Gonzalo; Juan José Lozano; Jenifer Muñoz; Francesc Balaguer; Maria Pellisé; Cristina Rodríguez de Miguel; Montserrat Andreu; Rodrigo Jover; Xavier Llor; M Dolores Giráldez; Teresa Ocaña; Anna Serradesanferm; Virginia Alonso-Espinaco; Mireya Jimeno; Miriam Cuatrecasas; Oriol Sendino; Sergi Castellví-Bel; Antoni Castells Journal: PLoS One Date: 2010-01-19 Impact factor: 3.240
Authors: Florian Eckhardt; Joern Lewin; Rene Cortese; Vardhman K Rakyan; John Attwood; Matthias Burger; John Burton; Tony V Cox; Rob Davies; Thomas A Down; Carolina Haefliger; Roger Horton; Kevin Howe; David K Jackson; Jan Kunde; Christoph Koenig; Jennifer Liddle; David Niblett; Thomas Otto; Roger Pettett; Stefanie Seemann; Christian Thompson; Tony West; Jane Rogers; Alex Olek; Kurt Berlin; Stephan Beck Journal: Nat Genet Date: 2006-10-29 Impact factor: 38.330
Authors: Eunjoo Kim; Laurie A Davidson; Roger S Zoh; Martha E Hensel; Bhimanagouda S Patil; Guddadarangavvanahally K Jayaprakasha; Evelyn S Callaway; Clinton D Allred; Nancy D Turner; Brad R Weeks; Robert S Chapkin Journal: Carcinogenesis Date: 2015-12-30 Impact factor: 4.944
Authors: Jaime A. Oliver; Jaime Gómez-Millán; Jose A. Medina; Laura Cabeza; Gloria Perazzoli; Cristina Jimenez-Luna; Kevin Doello; Raúl Ortiz Journal: Balkan Med J Date: 2019-06-14 Impact factor: 2.021